QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations. (Q44983984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Adrián Llerena

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Adrián Llerena

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Roland Berecz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alfredo de la Rubia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

189-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

Torsades de pointes and proarrhythmia

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Reversible coma caused by risperidone-ritonavir interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Electrophysiological effects of risperidone in mammalian cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Fatal cardiac event following initiation of risperidone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Antipsychotics and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104042618

21 January 2018

Identifiers

DOI

10.1177/0269881104042618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15260906%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference